Metformin Hydrochloride
Pricing Report NDC 68682-017-10

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Metformin Hydrochloride (NDC 68682-017-10) is $9.09140 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Dec 19, 2018.

As a provided by Oceanside Pharmaceuticals, this medication is distributed in a 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.09140
Per EA

Effective Date
Dec 19, 2018
Billable Units
100 EA
Estimated Package Price
$909.14
Data Status
As of Jan 30, 2019
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2017, the NADAC wholesale price for (NDC ) has moved within a range of $7.77940 to $45.79030 per EA. Over this 1 year and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$7.7794 - $45.7903
Market Volatility
488.61% Variance
Latest Trend
7.99%
Date Unit Price Unit Source Method Rate
Dec 19, 2018 $9.09140 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $9.09140 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 21, 2018 $9.88114 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 17, 2018 $7.77940 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 19, 2018 $12.75948 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 22, 2018 $10.55548 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $18.41930 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 23, 2018 $18.41930 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Apr 18, 2018 $12.48098 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2018 $14.67027 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 21, 2018 $14.67027 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jan 17, 2018 $15.91093 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2017 $18.23654 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 18, 2017 $18.23654 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 23, 2017 $32.84022 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2017 $32.84022 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 17, 2017 $30.25058 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 17, 2017 $30.25058 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Mar 29, 2017 $45.79030 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026